Article
Single-cell morphological and transcriptome analysis unveil inhibitors of polyploid giant breast cancer cells in vitro
21 Dec 2023
Abstract excerpt
Considerable evidence suggests that breast cancer therapeutic resistance and relapse can be driven by polyploid giant cancer cells (PGCCs). The number of PGCCs increases with the stages of disease and therapeutic stress. Given the importance of PGCCs, it remains challenging to eradicate them. To discover effective anti-PGCC compounds, there is an unmet need to rapidly distinguish compounds that kill non-PGCCs,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
